Affordable Access

Treatment with verapamil and trandolapril in patients with congestive heart failure and myocardial infarction. The Danish Verapamil Infarction Trial (DAVIT Study Group).

Authors
  • Hansen, J F
  • Hagerup, L
  • Sigurd, B
  • Pedersen, F
  • Mellemgaard, K
  • Pedersen-Bjergaard, O
Type
Published Article
Journal
Journal of hypertension. Supplement : official journal of the International Society of Hypertension
Publication Date
Mar 01, 1997
Volume
15
Issue
2
Identifiers
PMID: 9218208
Source
Medline
License
Unknown

Abstract

The Danish Verapamil Infarction Trial (DAVIT) study group hypothesized the combined treatment with trandolapril and verapamil might prevent cardiac events in postinfarct patients with coronary heart disease. The first double-blind randomized trial included 100 patients and supported this hypothesis, as the cardiac event rate was significantly lower after 3 months in patients treated with the combination than in those treated with trandolapril alone (14 versus 35%, respectively; P = 0.01, hazard ratio 0.35, 95% confidence interval 0.15-0.85).

Report this publication

Statistics

Seen <100 times